Blyth is the founder and former CEO of LIfT BioSciences, a company developing neutrophil-based immunotherapies designed to ...
A vaccine usually trains your immune system to recognize one target. Here, the target is basically “anything that doesn’t belong in the lungs.
An innovative approach supercharges the innate immune system to provide a first line of defence against respiratory ...
Study reveals how two proteins cooperate in a key early step of antiviral detection, as reported by researchers at Science ...
A new Stanford study marks a big step forward in the creation of a new kind of vaccine that offers protection against a range ...
A new Stanford study marks a big step forward in the creation of a new kind of vaccine that offers protection against a range of infections at once.
Secondary infections caused by bacteria or viruses during hospital care remain a long-standing global challenge, despite advances in modern medicine. In particular, mixed bacterial–viral infections in ...
A new Stanford study published Thursday marks a big step forward in the creation of a new kind of vaccine that offers ...